PMID- 24339874 OWN - NLM STAT- MEDLINE DCOM- 20150302 LR - 20240313 IS - 1932-6203 (Electronic) IS - 1932-6203 (Linking) VI - 8 IP - 12 DP - 2013 TI - Adult human glia, pericytes and meningeal fibroblasts respond similarly to IFNy but not to TGFbeta1 or M-CSF. PG - e80463 LID - 10.1371/journal.pone.0080463 [doi] LID - e80463 AB - The chemokine Interferon gamma-induced protein 10 (IP-10) and human leukocyte antigen (HLA) are widely used indicators of glial activation and neuroinflammation and are up-regulated in many brain disorders. These inflammatory mediators have been widely studied in rodent models of brain disorders, but less work has been undertaken using human brain cells. In this study we investigate the regulation of HLA and IP-10, as well as other cytokines and chemokines, in microglia, astrocytes, pericytes, and meningeal fibroblasts derived from biopsy and autopsy adult human brain, using immunocytochemistry and a Cytometric Bead Array. Interferongamma (IFNgamma) increased microglial HLA expression, but contrary to data in rodents, the anti-inflammatory cytokine transforming growth factor beta1 (TGFbeta1) did not inhibit this increase in HLA, nor did TGFbeta1 affect basal microglial HLA expression or IFNgamma-induced astrocytic HLA expression. In contrast, IFNgamma-induced and basal microglial HLA expression, but not IFNgamma-induced astrocytic HLA expression, were strongly inhibited by macrophage colony stimulating factor (M-CSF). IFNgamma also strongly induced HLA expression in pericytes and meningeal fibroblasts, which do not basally express HLA, and this induction was completely blocked by TGFbeta1, but not affected by M-CSF. In contrast, TGFbeta1 did not block the IFNgamma-induced increase in IP-10 in pericytes and meningeal fibroblasts. These results show that IFNgamma, TGFbeta1 and M-CSF have species- and cell type-specific effects on human brain cells that may have implications for their roles in adult human brain inflammation. FAU - Smith, Amy M AU - Smith AM AD - Department of Pharmacology and Clinical Pharmacology, The University of Auckland, Auckland, New Zealand ; Gravida - National Research Centre for Growth and Development, Auckland, New Zealand ; Centre for Brain Research, The University of Auckland, Auckland, New Zealand. FAU - Graham, E Scott AU - Graham ES FAU - Feng, Sheryl Xia AU - Feng SX FAU - Oldfield, Robyn L AU - Oldfield RL FAU - Bergin, Peter M AU - Bergin PM FAU - Mee, Edward W AU - Mee EW FAU - Faull, Richard L M AU - Faull RL FAU - Curtis, Maurice A AU - Curtis MA FAU - Dragunow, Mike AU - Dragunow M LA - eng GR - G0901113/MRC_/Medical Research Council/United Kingdom PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20131205 PL - United States TA - PLoS One JT - PloS one JID - 101285081 RN - 0 (Chemokines) RN - 0 (HLA-D Antigens) RN - 0 (Transforming Growth Factor beta1) RN - 81627-83-0 (Macrophage Colony-Stimulating Factor) RN - 82115-62-6 (Interferon-gamma) SB - IM MH - Adult MH - Astrocytes/cytology MH - Chemokines/metabolism MH - Fibroblasts/*drug effects/metabolism MH - Gene Expression Regulation/drug effects MH - HLA-D Antigens/metabolism MH - Humans MH - Interferon-gamma/*pharmacology MH - Macrophage Colony-Stimulating Factor/*pharmacology MH - Meninges/*cytology MH - Neuroglia/*cytology MH - Pericytes/*cytology MH - Transforming Growth Factor beta1/*pharmacology PMC - PMC3855168 COIS- Competing Interests: The authors have declared that no competing interests exist. EDAT- 2013/12/18 06:00 MHDA- 2015/03/03 06:00 PMCR- 2013/12/05 CRDT- 2013/12/17 06:00 PHST- 2013/08/14 00:00 [received] PHST- 2013/10/02 00:00 [accepted] PHST- 2013/12/17 06:00 [entrez] PHST- 2013/12/18 06:00 [pubmed] PHST- 2015/03/03 06:00 [medline] PHST- 2013/12/05 00:00 [pmc-release] AID - PONE-D-13-33776 [pii] AID - 10.1371/journal.pone.0080463 [doi] PST - epublish SO - PLoS One. 2013 Dec 5;8(12):e80463. doi: 10.1371/journal.pone.0080463. eCollection 2013.